{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T15:47:21Z","timestamp":1780069641707,"version":"3.54.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.clineuro.2023.108079","type":"journal-article","created":{"date-parts":[[2023,12,9]],"date-time":"2023-12-09T21:19:13Z","timestamp":1702156753000},"page":"108079","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["The role of surgical management for prolactin-secreting tumors in the era of dopaminergic agonists: An international multicenter report"],"prefix":"10.1016","volume":"236","author":[{"given":"Matthew C.","family":"Findlay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadmahdi","family":"Sabahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Azab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Drexler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Rotermund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz L.","family":"Ricklefs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Flitsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy R.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John L.","family":"Kilgallon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Honegger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2226-4958","authenticated-orcid":false,"given":"Isabella","family":"Nasi-Kordhishti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Gardner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary C.","family":"Gersey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussein M.","family":"Abdallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Jane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich J.","family":"Knappe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nesrin","family":"Uksul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry W.S.","family":"Schroder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6445-0620","authenticated-orcid":false,"given":"M\u00e1rton","family":"E\u00f6rd\u00f6gh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Losa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Mortini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00fcdiger","family":"Gerlach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apio C.M.","family":"Antunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William T.","family":"Couldwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karol P.","family":"Budohoski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C.","family":"Rennert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0422-7937","authenticated-orcid":false,"given":"Michael","family":"Karsy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.clineuro.2023.108079_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.lpm.2021.104080","article-title":"Prolactinomas","volume":"50","author":"Wildemberg","year":"2021","journal-title":"Presse Med."},{"key":"10.1016\/j.clineuro.2023.108079_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2021.106942","article-title":"Patterns of extrasellar invasive growth of pituitary adenomas with normal sellar cavity size","volume":"209","author":"Sharifi","year":"2021","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"1","key":"10.1016\/j.clineuro.2023.108079_bib3","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000499470","article-title":"Dopamine agonists: from the 1970s to today","volume":"109","author":"Auriemma","year":"2019","journal-title":"Neuroendocrinology"},{"issue":"1","key":"10.1016\/j.clineuro.2023.108079_bib4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/17446651.2018.1411798","article-title":"Medical versus surgical treatment of prolactinomas: an analysis of treatment outcomes","volume":"13","author":"Rutkowski","year":"2018","journal-title":"Expert Rev. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.clineuro.2023.108079_bib5","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1210\/clinem\/dgz144","article-title":"Surgery as a viable alternative first-line treatment for prolactinoma patients. a systematic review and meta-analysis","volume":"105","author":"Zamanipoor Najafabadi","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1\u20133","key":"10.1016\/j.clineuro.2023.108079_bib6","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1023\/B:NEON.0000041886.61149.ab","article-title":"Transsphenoidal and transcranial surgery for pituitary adenomas","volume":"69","author":"Couldwell","year":"2004","journal-title":"J. Neurooncol."},{"issue":"1","key":"10.1016\/j.clineuro.2023.108079_bib7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1530\/EJE-07-0248","article-title":"Operative treatment of prolactinomas: indications and results in a current consecutive series of 212 patients","volume":"158","author":"Kreutzer","year":"2008","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"10.1016\/j.clineuro.2023.108079_bib8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1530\/eje.0.1400043","article-title":"Trans-sphenoidal surgery for microprolactinoma: an acceptable alternative to dopamine agonists?","volume":"140","author":"Turner","year":"1999","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"10.1016\/j.clineuro.2023.108079_bib9","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1530\/EO-21-0038","article-title":"Dopamine agonist therapy for prolactinomas: do we need to rethink the place of surgery in prolactinoma management?","volume":"2","author":"De Sousa","year":"2022","journal-title":"Endocr. Oncol."},{"issue":"2","key":"10.1016\/j.clineuro.2023.108079_bib10","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3171\/jns.2002.97.2.0307","article-title":"Predictive value of serum prolactin levels measured immediately after transsphenoidal surgery","volume":"97","author":"Amar","year":"2002","journal-title":"J. Neurosurg."},{"issue":"13","key":"10.1016\/j.clineuro.2023.108079_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13133252","article-title":"Reappraising the role of trans-sphenoidal surgery in prolactin-secreting pituitary tumors","volume":"13","author":"Mattogno","year":"2021","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.clineuro.2023.108079_bib12","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.nec.2019.05.010","article-title":"The role of surgery in the management of prolactinomas","volume":"30","author":"Donoho","year":"2019","journal-title":"Neurosurg. Clin. N. Am."},{"issue":"3","key":"10.1016\/j.clineuro.2023.108079_bib13","first-page":"128","article-title":"The neurosurgical management of prolactinomas","volume":"44","author":"G\u00f6kalp","year":"2000","journal-title":"J. Neurosurg. Sci."},{"issue":"5","key":"10.1016\/j.clineuro.2023.108079_bib14","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s00701-016-2762-z","article-title":"Reasons and results of endoscopic surgery for prolactinomas: 142 surgical cases","volume":"158","author":"Akin","year":"2016","journal-title":"Acta Neurochir."},{"issue":"5","key":"10.1016\/j.clineuro.2023.108079_bib15","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.beem.2009.05.002","article-title":"Surgical treatment of pituitary tumours","volume":"23","author":"Buchfelder","year":"2009","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.clineuro.2023.108079_bib16","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000495775","article-title":"Management of dopamine agonist-resistant prolactinoma","volume":"109","author":"Maiter","year":"2019","journal-title":"Neuroendocrinology"},{"issue":"1","key":"10.1016\/j.clineuro.2023.108079_bib17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11102-019-00987-3","article-title":"Dopamine agonist resistant prolactinomas: any alternative medical treatment?","volume":"23","author":"Souteiro","year":"2020","journal-title":"Pituitary"},{"issue":"3","key":"10.1016\/j.clineuro.2023.108079_bib18","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgz076","article-title":"Impulse control disorders in dopamine agonist-treated hyperprolactinemia: prevalence and risk factors","volume":"105","author":"De Sousa","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.clineuro.2023.108079_bib19","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1210\/jc.2018-02202","article-title":"Dopamine agonist-induced impulse control disorders in patients with prolactinoma: a cross-sectional multicenter study","volume":"104","author":"Dogansen","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.clineuro.2023.108079_bib20","first-page":"1","article-title":"Prolactinoma extension as a contributing factor in dopamine agonist-induced CSF rhinorrhea: a systematic review of the literature","author":"Milton","year":"2021","journal-title":"Br. J. Neurosurg."},{"key":"10.1016\/j.clineuro.2023.108079_bib21","doi-asserted-by":"crossref","first-page":"e349","DOI":"10.1016\/j.wneu.2021.07.035","article-title":"Determinants of surgical remission in prolactinomas: a systematic review and meta-analysis","volume":"154","author":"Wright","year":"2021","journal-title":"World Neurosurg."},{"issue":"2","key":"10.1016\/j.clineuro.2023.108079_bib22","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1210\/jc.2010-1692","article-title":"Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline","volume":"96","author":"Melmed","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.clineuro.2023.108079_bib23","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1445-5994.2010.02410.x","article-title":"Dopamine agonists in the treatment of prolactinoma: are they still first choice?","volume":"41","author":"Ogilvie","year":"2011","journal-title":"Intern. Med. J."},{"issue":"2","key":"10.1016\/j.clineuro.2023.108079_bib24","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s11102-013-0480-6","article-title":"Investigation of impulsivity in patients on dopamine agonist therapy for hyperprolactinemia: a pilot study","volume":"17","author":"Barake","year":"2014","journal-title":"Pituitary"},{"issue":"3","key":"10.1016\/j.clineuro.2023.108079_bib25","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00701-022-05456-8","article-title":"Remission, complications, and overall survival in transsphenoidal pituitary surgery-a Swedish single-center experience of 578 patients","volume":"165","author":"Bengtsson","year":"2023","journal-title":"Acta Neurochir."},{"issue":"3","key":"10.1016\/j.clineuro.2023.108079_bib26","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00701-013-1959-7","article-title":"Surgical complications after transsphenoidal microscopic and endoscopic surgery for pituitary adenoma: a consecutive series of 506 procedures","volume":"156","author":"Halvorsen","year":"2014","journal-title":"Acta Neurochir."},{"issue":"4","key":"10.1016\/j.clineuro.2023.108079_bib27","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/neuros\/nyy385","article-title":"Endoscopic transsphenoidal surgery of microprolactinomas: a reappraisal of cure rate based on radiological criteria","volume":"85","author":"Micko","year":"2019","journal-title":"Neurosurgery"},{"key":"10.1016\/j.clineuro.2023.108079_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2018.00636","article-title":"The chance of permanent cure for micro- and macroprolactinomas, medication or surgery? A systematic review and meta-analysis","volume":"9","author":"Ma","year":"2018","journal-title":"Front. Endocrinol."},{"issue":"3","key":"10.1016\/j.clineuro.2023.108079_bib29","doi-asserted-by":"crossref","first-page":"R89","DOI":"10.1530\/EJE-16-0087","article-title":"Therapy of endocrine disease: surgery in microprolactinomas: effectiveness and risks based on contemporary literature","volume":"175","author":"Tampourlou","year":"2016","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"10.1016\/j.clineuro.2023.108079_bib30","doi-asserted-by":"crossref","DOI":"10.1186\/s41016-022-00277-1","article-title":"Are dopamine agonists still the first-choice treatment for prolactinoma in the era of endoscopy? A systematic review and meta-analysis","volume":"8","author":"Cai","year":"2022","journal-title":"Chin. Neurosurg. J."},{"issue":"10","key":"10.1016\/j.clineuro.2023.108079_bib31","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvab074","article-title":"Cure and hormonal control after prolactinoma resection: case series and systematic review","volume":"5","author":"Penn","year":"2021","journal-title":"J. Endocr. Soc."},{"issue":"5","key":"10.1016\/j.clineuro.2023.108079_bib32","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.3171\/2010.11.JNS101369","article-title":"Dopamine agonist-resistant prolactinomas","volume":"114","author":"Oh","year":"2011","journal-title":"J. Neurosurg."},{"issue":"6","key":"10.1016\/j.clineuro.2023.108079_bib33","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1159\/000504000","article-title":"Treatment of pituitary and other tumours with cabergoline: new mechanisms and potential broader applications","volume":"110","author":"Lin","year":"2020","journal-title":"Neuroendocrinology"},{"issue":"4","key":"10.1016\/j.clineuro.2023.108079_bib34","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s11102-017-0806-x","article-title":"Prolactinoma management: predictors of remission and recurrence after dopamine agonists withdrawal","volume":"20","author":"Teixeira","year":"2017","journal-title":"Pituitary"},{"issue":"15","key":"10.1016\/j.clineuro.2023.108079_bib35","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2021.36.e97","article-title":"Long-term outcome of microscopic transsphenoidal surgery for prolactinomas as an alternative to dopamine agonists","volume":"36","author":"Park","year":"2021","journal-title":"J. Korean Med Sci."},{"issue":"5","key":"10.1016\/j.clineuro.2023.108079_bib36","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1530\/EJE-11-1000","article-title":"Outcomes of transsphenoidal surgery in prolactinomas: improvement of hormonal control in dopamine agonist-resistant patients","volume":"166","author":"Primeau","year":"2012","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"10.1016\/j.clineuro.2023.108079_bib37","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000497331","article-title":"Surgery for prolactinomas to date","volume":"109","author":"Buchfelder","year":"2019","journal-title":"Neuroendocrinology"},{"issue":"1","key":"10.1016\/j.clineuro.2023.108079_bib38","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11102-005-5086-1","article-title":"Surgical outcomes in hyporesponsive prolactinomas: analysis of patients with resistance or intolerance to dopamine agonists","volume":"8","author":"Hamilton","year":"2005","journal-title":"Pituitary"},{"issue":"10","key":"10.1016\/j.clineuro.2023.108079_bib39","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.jocn.2015.03.059","article-title":"Update on prolactinomas. Part 2: treatment and management strategies","volume":"22","author":"Wong","year":"2015","journal-title":"J. Clin. Neurosci."},{"issue":"1","key":"10.1016\/j.clineuro.2023.108079_bib40","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s11102-010-0261-4","article-title":"Effect of dopaminergic drug treatment on surgical findings in prolactinomas","volume":"14","author":"Menucci","year":"2011","journal-title":"Pituitary"},{"key":"10.1016\/j.clineuro.2023.108079_bib41","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2017-220971","article-title":"Cabergoline-induced fibrosis of prolactinomas: a neurosurgical perspective","volume":"2017","author":"Mohan","year":"2017","journal-title":"BMJ Case Rep."},{"issue":"6","key":"10.1016\/j.clineuro.2023.108079_bib42","doi-asserted-by":"crossref","first-page":"816","DOI":"10.3171\/jns.1987.67.6.0816","article-title":"Prolactin-secreting adenomas: the preoperative response to bromocriptine treatment and surgical outcome","volume":"67","author":"Hubbard","year":"1987","journal-title":"J. Neurosurg."},{"issue":"4","key":"10.1016\/j.clineuro.2023.108079_bib43","doi-asserted-by":"crossref","first-page":"899","DOI":"10.21608\/ejhm.2019.25556","article-title":"Does dopamine agonist hormonal therapy for macro-prolactinoma affect future surgery?","volume":"74","author":"Kandeel","year":"2019","journal-title":"Egypt. J. Hosp. Med."},{"issue":"3","key":"10.1016\/j.clineuro.2023.108079_bib44","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s11102-008-0135-1","article-title":"Pre-operative dopamine agonist therapy improves post-operative tumor control following prolactinoma resection","volume":"12","author":"Sughrue","year":"2009","journal-title":"Pituitary"},{"issue":"1","key":"10.1016\/j.clineuro.2023.108079_bib45","doi-asserted-by":"crossref","DOI":"10.1186\/s12902-020-0543-4","article-title":"Predictors of dopamine agonist resistance in prolactinoma patients","volume":"20","author":"Vermeulen","year":"2020","journal-title":"BMC Endocr. Disord."},{"issue":"4","key":"10.1016\/j.clineuro.2023.108079_bib46","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1210\/jc.2009-1191","article-title":"Prognostic factors in prolactin pituitary tumors: clinical, histological, and molecular data from a series of 94 patients with a long postoperative follow-up","volume":"95","author":"Raverot","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"45","key":"10.1016\/j.clineuro.2023.108079_bib47","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000013198","article-title":"Retrospective analysis of 52 patients with prolactinomas following endoscopic endonasal transsphenoidal surgery","volume":"97","author":"Han","year":"2018","journal-title":"Medicine"},{"issue":"1","key":"10.1016\/j.clineuro.2023.108079_bib48","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-12980-1","article-title":"Prospective intraoperative and histologic evaluation of cavernous sinus medial wall invasion by pituitary adenomas and its implications for acromegaly remission outcomes","volume":"12","author":"Mohyeldin","year":"2022","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.clineuro.2023.108079_bib49","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/00000421-200208000-00023","article-title":"Relapsed prolactinoma 27 years after conventional radiotherapy","volume":"25","author":"K\u00f6kl\u00fc","year":"2002","journal-title":"Am. J. Clin. Oncol."}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030384672300495X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030384672300495X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T18:41:08Z","timestamp":1753296068000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030384672300495X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":49,"alternative-id":["S030384672300495X"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2023.108079","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of surgical management for prolactin-secreting tumors in the era of dopaminergic agonists: An international multicenter report","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2023.108079","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108079"}}